JP2023522644A5 - - Google Patents
Info
- Publication number
- JP2023522644A5 JP2023522644A5 JP2022562465A JP2022562465A JP2023522644A5 JP 2023522644 A5 JP2023522644 A5 JP 2023522644A5 JP 2022562465 A JP2022562465 A JP 2022562465A JP 2022562465 A JP2022562465 A JP 2022562465A JP 2023522644 A5 JP2023522644 A5 JP 2023522644A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025230606A JP2026041886A (ja) | 2020-04-17 | 2025-12-04 | プレウロムチリンの治療的使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011474P | 2020-04-17 | 2020-04-17 | |
| EP20170072.1 | 2020-04-17 | ||
| US63/011,474 | 2020-04-17 | ||
| EP20170072 | 2020-04-17 | ||
| EP20183292.0 | 2020-06-30 | ||
| EP20183292 | 2020-06-30 | ||
| PCT/EP2021/025140 WO2021209174A1 (en) | 2020-04-17 | 2021-04-16 | Therapeutic use of pleuromutilins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025230606A Division JP2026041886A (ja) | 2020-04-17 | 2025-12-04 | プレウロムチリンの治療的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522644A JP2023522644A (ja) | 2023-05-31 |
| JP2023522644A5 true JP2023522644A5 (https=) | 2025-07-30 |
| JPWO2021209174A5 JPWO2021209174A5 (https=) | 2025-07-30 |
Family
ID=75801547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562465A Pending JP2023522644A (ja) | 2020-04-17 | 2021-04-16 | プレウロムチリンの治療的使用 |
| JP2025230606A Pending JP2026041886A (ja) | 2020-04-17 | 2025-12-04 | プレウロムチリンの治療的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025230606A Pending JP2026041886A (ja) | 2020-04-17 | 2025-12-04 | プレウロムチリンの治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230174472A1 (https=) |
| EP (1) | EP4135682A1 (https=) |
| JP (2) | JP2023522644A (https=) |
| CN (1) | CN115443131A (https=) |
| BR (1) | BR112022020007A2 (https=) |
| CA (1) | CA3180535A1 (https=) |
| IL (1) | IL297268A (https=) |
| TW (1) | TW202203908A (https=) |
| WO (1) | WO2021209174A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250134844A1 (en) | 2022-02-09 | 2025-05-01 | Nabriva Therapeutics GmbH | Therapeutic use of pleuromutilins |
| EP4338732A1 (en) | 2022-09-16 | 2024-03-20 | Nabriva Therapeutics GMBH | Lefamulin and its derivatives for use in the treatment of tularemia |
| CN119925362A (zh) * | 2023-11-03 | 2025-05-06 | 阳光安津(南京)生物医药科技有限公司 | 一种化合物在制备用于治疗银屑病的药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298733B1 (en) * | 2005-06-27 | 2016-05-25 | Nabriva Therapeutics AG | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
| EP1972618A1 (en) | 2007-03-20 | 2008-09-24 | Nabriva Therapeutics AG | Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| GB0803707D0 (en) | 2008-02-28 | 2008-04-09 | Cambridge Entpr Ltd | Antiviral agent |
| EP2399904A1 (en) * | 2010-05-26 | 2011-12-28 | Nabriva Therapeutics AG | Process for the preparation of pleuromutilins |
| CN103204787B (zh) | 2012-01-17 | 2014-10-01 | 北京艾百诺科技有限公司 | 含有取代方酸的乙酸妙林酯及其应用 |
| CN103242210B (zh) | 2012-02-09 | 2014-09-24 | 北京艾百诺科技有限公司 | 含有取代方酸的乙酸妙林酯及其应用 |
| KR102656841B1 (ko) | 2015-06-17 | 2024-04-12 | 나브리바 테라퓨틱스 게엠베하 | 레파뮬린의 주사가능한 약제학적 제형 |
| CN110507823B (zh) * | 2019-08-20 | 2021-08-24 | 中国医学科学院基础医学研究所 | 衣康酸相关物质在诊断、防治病毒感染性疾病中的应用 |
-
2021
- 2021-04-16 CN CN202180028994.6A patent/CN115443131A/zh active Pending
- 2021-04-16 IL IL297268A patent/IL297268A/en unknown
- 2021-04-16 TW TW110113773A patent/TW202203908A/zh unknown
- 2021-04-16 US US17/919,200 patent/US20230174472A1/en active Pending
- 2021-04-16 BR BR112022020007A patent/BR112022020007A2/pt not_active Application Discontinuation
- 2021-04-16 JP JP2022562465A patent/JP2023522644A/ja active Pending
- 2021-04-16 EP EP21723641.3A patent/EP4135682A1/en active Pending
- 2021-04-16 WO PCT/EP2021/025140 patent/WO2021209174A1/en not_active Ceased
- 2021-04-16 CA CA3180535A patent/CA3180535A1/en active Pending
-
2025
- 2025-12-04 JP JP2025230606A patent/JP2026041886A/ja active Pending